Skip to Content
Merck
CN
All Photos(1)

Documents

1270708

USP

Flavoxate hydrochloride

United States Pharmacopeia (USP) Reference Standard

Sign Into View Organizational & Contract Pricing
All Photos(1)
Synonym(s):
3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester hydrochloride, DW-61, Rec-7-0040
Empirical Formula (Hill Notation):
C24H25NO4 · HCl
CAS Number:
3717-88-2
Molecular Weight:
427.92
MDL number:
MFCD00072099
UNSPSC Code:
41116107
PubChem Substance ID:
329749847
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

flavoxate

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

Cl[H].CC1=C(Oc2c(cccc2C1=O)C(=O)OCCN3CCCCC3)c4ccccc4

InChI

1S/C24H25NO4.ClH/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25;/h2,4-5,8-12H,3,6-7,13-16H2,1H3;1H

InChI key

XOEVKNFZUQEERE-UHFFFAOYSA-N

Gene Information

human ... PDE4A(5141) , PDE4B(5142) , PDE4C(5143) , PDE4D(5144) , PDE7A(5150) , PDE7B(27115) , PDE8A(5151) , PDE8B(8622)

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Biochem/physiol Actions

L-type Ca2+ (Cav1.2) channel inhibitor

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

Y0000736

Flavoxate hydrochloride, European Pharmacopoeia (EP) Reference Standard

Y0000737

Flavoxate impurity A, European Pharmacopoeia (EP) Reference Standard

Y0000738

Flavoxate impurity B, European Pharmacopoeia (EP) Reference Standard

1270719

Flavoxate Related Compound A, United States Pharmacopeia (USP) Reference Standard

1270731

Flavoxate Related Compound C, United States Pharmacopeia (USP) Reference Standard

1270720

Flavoxate Related Compound B, United States Pharmacopeia (USP) Reference Standard

BP571

Flavoxate hydrochloride, British Pharmacopoeia (BP) Reference Standard

BP569

3-Methylflavone-8-carboxylic acid, British Pharmacopoeia (BP) Reference Standard

PHR3008

Flavoxate Related Compound B, pharmaceutical secondary standard, certified reference material

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302,H335

Hazard Classifications

Acute Tox. 4 Oral - STOT SE 3

Target Organs

Respiratory system

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

R Ruffmann
The Journal of international medical research, 16(5), 317-330 (1988-09-01)
This article provides a review of the use of flavoxate hydrochloride in the treatment of urge incontinence. It outlines the pharmacology, mode of action, toxicology and pharmacokinetic studies which have been carried out, and then reviews the clinical studies, including

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service